Secreted PGE2 and 20-HETE bind to prostaglandin E2 receptors (EP) and GPCR, respectively, then activate the PI3K/Akt and MAPK/Erk signaling pathways, promoting cell proliferation, migration and anti-oxidative stress in triple-negative breast cancer. Here, AKT1 is linked to triple-negative breast carcinoma.